| P2093 | author name string | Domenico Praticò | |
| | Jin Chu | |
| P2860 | cites work | Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice | Q35750756 |
| | 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease | Q36299503 |
| | Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease | Q36774177 |
| | 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease | Q37232572 |
| | Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease | Q37441782 |
| | The role of tau in Alzheimer's disease and related disorders | Q37765632 |
| | Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes. | Q39207637 |
| | Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase | Q39689586 |
| | Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. | Q44720653 |
| | Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. | Q46081295 |
| | Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. | Q46303283 |
| | Alzheimer's Disease | Q22248111 |
| | Tauopathies | Q22252803 |
| | p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton | Q28145210 |
| | Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 |
| | Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model | Q29617937 |
| | 5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo | Q34636148 |
| | Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of γ-secretase | Q34805615 |
| | Tau in Alzheimer disease and related tauopathies | Q34953869 |
| | Cdk5: One of the links between senile plaques and neurofibrillary tangles? | Q35116571 |
| | Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? | Q35594823 |
| P433 | issue | 6 | |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 1549-1554 | |
| P577 | publication date | 2013-01-16 | |
| P1433 | published in | Neurobiology of Aging | Q7002141 |
| P1476 | title | 5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5. | |
| P478 | volume | 34 | |